These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11809705)

  • 1. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
    Halmos B; Huettner CS; Kocher O; Ferenczi K; Karp DD; Tenen DG
    Cancer Res; 2002 Jan; 62(2):528-34. PubMed ID: 11809705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
    Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
    Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
    Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.
    Halmos B; Bassères DS; Monti S; D'Aló F; Dayaram T; Ferenczi K; Wouters BJ; Huettner CS; Golub TR; Tenen DG
    Cancer Res; 2004 Jun; 64(12):4137-47. PubMed ID: 15205324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance.
    Tomizawa M; Horie H; Yamamoto H; Matsunaga T; Sasaki F; Hashizume K; Hiyama E; Kaneko M; Suita S; Ando H; Hayashi Y; Ohnuma N; Nakagawara A
    Oncol Rep; 2007 Feb; 17(2):341-4. PubMed ID: 17203171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
    Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
    Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
    Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
    Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
    Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
    Yin H; Smith M; Glass J
    Prostate; 2005 Feb; 62(3):209-16. PubMed ID: 15389791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.
    Levin WJ; Press MF; Gaynor RB; Sukhatme VP; Boone TC; Reissmann PT; Figlin RA; Holmes EC; Souza LM; Slamon DJ
    Oncogene; 1995 Oct; 11(7):1261-9. PubMed ID: 7478546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of the CCAAT/enhancer binding protein alpha gene involved in hepatocyte proliferation in human hepatocellular carcinomas.
    Tomizawa M; Wang YQ; Ebara M; Saisho H; Watanabe K; Nakagawara A; Tagawa M
    Int J Mol Med; 2002 Jun; 9(6):597-600. PubMed ID: 12011976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
    Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased PITX1 homeobox gene expression in human lung cancer.
    Chen Y; Knösel T; Ye F; Pacyna-Gengelbach M; Deutschmann N; Petersen I
    Lung Cancer; 2007 Mar; 55(3):287-94. PubMed ID: 17157953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
    Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
    Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.